Drug Enforcement Administration 2020 – Federal Register Recent Federal Regulation Documents

Results 101 - 150 of 241
Importer of Controlled Substances Application: Epic Pharma, LLC
Document Number: 2020-17432
Type: Notice
Date: 2020-08-11
Agency: Drug Enforcement Administration, Department of Justice
Epic Pharma, LLC applied to be registered as an importer of the following basic class(es) of a controlled substance: Methadone.
Tommy L. Louisville, M.D.; Decision and Order
Document Number: 2020-17373
Type: Notice
Date: 2020-08-10
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc
Document Number: 2020-16775
Type: Notice
Date: 2020-08-03
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Curium US LLC
Document Number: 2020-16774
Type: Notice
Date: 2020-08-03
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Chattem Chemicals Inc
Document Number: 2020-16773
Type: Notice
Date: 2020-08-03
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Euticals Inc.
Document Number: 2020-16401
Type: Notice
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Document Number: 2020-16397
Type: Notice
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
Salvatore Cavaliere, D.O.; Decision and Order
Document Number: 2020-16388
Type: Notice
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
Kaniz F. Khan-Jaffery, M.D.; Decision and Order
Document Number: 2020-16387
Type: Notice
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
Hamada Makarita, D.D.S.; Denial of Application
Document Number: 2020-16355
Type: Notice
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
Reporting of Theft or Significant Loss of Controlled Substances
Document Number: 2020-15635
Type: Proposed Rule
Date: 2020-07-29
Agency: Drug Enforcement Administration, Department of Justice
This proposed rule would amend Drug Enforcement Administration (DEA) regulations regarding DEA Form 106, used by DEA registrants to report thefts or significant losses of controlled substances, to clarify that all such forms must be submitted electronically. In addition, the proposed rule would add new requirements for the form to be submitted accurately and within a 15-day time period. This proposed rule will not change the requirement that registrants notify the DEA Field Division Office in their area, in writing, of the theft or significant loss of any controlled substances within one business day of discovery of such loss or theft.
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals Virginia, LLC
Document Number: R1-2020-16100
Type: Notice
Date: 2020-07-28
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Ampac Fine Chemicals LLC
Document Number: C1-2020-16104
Type: Notice
Date: 2020-07-28
Agency: Drug Enforcement Administration, Department of Justice
Frederick M. Silvers, M.D.; Decision and Order
Document Number: 2020-16343
Type: Notice
Date: 2020-07-28
Agency: Drug Enforcement Administration, Department of Justice
Frank Joseph Stirlacci, M.D.; Decision and Order
Document Number: 2020-16193
Type: Notice
Date: 2020-07-27
Agency: Drug Enforcement Administration, Department of Justice
Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants
Document Number: 2020-16169
Type: Rule
Date: 2020-07-24
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is adjusting the fee schedule for registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and list I chemicals as mandated by the Controlled Substances Act (CSA). This final rule adopts the notice of proposed rulemaking published on March 16, 2020, to change the fee schedule and codify existing practices of the issuance of refunds by DEA for applicant registration fees, without change.
Bulk Manufacturer of Controlled Substances Application: Ampac Fine Chemicals LLC
Document Number: 2020-16104-2
Type: Notice
Date: 2020-07-24
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Ampac Fine Chemicals LLC
Document Number: 2020-16104
Type: Notice
Date: 2020-07-24
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Arizona Department of Corrections
Document Number: 2020-16103
Type: Notice
Date: 2020-07-24
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Document Number: 2020-15465
Type: Notice
Date: 2020-07-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cambrex Charles City
Document Number: 2020-15464
Type: Notice
Date: 2020-07-17
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act
Document Number: 2020-14902
Type: Rule
Date: 2020-07-13
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of naphthalen-1-yl 1-(5-fluoropentyl)-1H- indole-3-carboxylate (trivial names: NM2201; CBL2201), N-(1-amino-3- methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carb oxamide (trivial name: 5F-AB-PINACA), 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)- 1H-indazole-3-carboxamide (trivial names: 4-CN-CUMYL-BUTINACA; 4-cyano- CUMYL-BUTINACA; 4-CN-CUMYL-BINACA; CUMYL-4CN-BINACA, SGT-78), methyl 2- (1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutano ate (trivial names: MMB-CHMICA, AMB-CHMICA), and 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA), including their optical, positional, and geometric isomers, salts, and salts of isomers. The schedule I status of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL- P7AICA currently is in effect until July 10, 2020. This temporary order will extend the temporary scheduling of NM2201, 5F-AB-PINACA, 4-CN- CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA for one year or until the permanent scheduling action for these substances is completed, whichever occurs first.
Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I
Document Number: 2020-14901
Type: Proposed Rule
Date: 2020-07-13
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes placing naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (trivial names: NM2201; CBL2201), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide (trivial name: 5F-AB-PINACA), 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carbox amide (trivial names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA, SGT-78), methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3-methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA), and 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle NM2201, 5F-AB- PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA.
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Document Number: 2020-14781
Type: Notice
Date: 2020-07-09
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Usona Institute
Document Number: 2020-14624
Type: Notice
Date: 2020-07-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Xcelience
Document Number: 2020-14623
Type: Notice
Date: 2020-07-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Galephar Pharmaceutical Research, Inc.
Document Number: 2020-14614
Type: Notice
Date: 2020-07-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Lipomed
Document Number: 2020-14605
Type: Notice
Date: 2020-07-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Document Number: 2020-13336
Type: Notice
Date: 2020-06-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I
Document Number: 2020-12304
Type: Proposed Rule
Date: 2020-06-18
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine (commonly known as isotonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle isotonitazene.
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Document Number: 2020-13009
Type: Notice
Date: 2020-06-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Woodfield Distribution, LLC
Document Number: 2020-13008
Type: Notice
Date: 2020-06-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Document Number: 2020-12858
Type: Notice
Date: 2020-06-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Exempt Anabolic Steroid Products
Document Number: 2020-11318
Type: Rule
Date: 2020-06-15
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is designating two pharmaceutical preparations containing esterified estrogens and methyltestosterone as exempt anabolic steroid products under the Controlled Substances Act.
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Document Number: C1-2020-10601
Type: Notice
Date: 2020-06-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cardinal Health
Document Number: 2020-12625
Type: Notice
Date: 2020-06-11
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Honeoye Manufacturing
Document Number: 2020-12383
Type: Notice
Date: 2020-06-09
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to proposed regulations that, if finalized, would govern the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2020-12377
Type: Notice
Date: 2020-06-09
Agency: Drug Enforcement Administration, Department of Justice
Listing of Ethylone in Schedule I of Controlled Substances and Assignment of an Administration Controlled Substances Code Number
Document Number: 2020-10295
Type: Rule
Date: 2020-06-08
Agency: Drug Enforcement Administration, Department of Justice
This is a final rule issued by the Drug Enforcement Administration (DEA) establishing a specific listing and administration controlled substances code number for ethylone (also known as 1-(1,3- benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4-methylenedioxy-N- ethylcathinone; bk-MDEA; MDEC) in schedule I of the Controlled Substances Act (CSA).
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2020-12180
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2020-12177
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Nalas Engineering Services, Inc.
Document Number: 2020-12175
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2020-12086
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Bellwyck Clinical Services
Document Number: 2020-12082
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Akorn, Inc.
Document Number: 2020-12080
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Agilent Technologies
Document Number: 2020-11546
Type: Notice
Date: 2020-05-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2020-11393
Type: Notice
Date: 2020-05-28
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.
Document Number: 2020-11077
Type: Notice
Date: 2020-05-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Biopharmaceutical Research Company LLC
Document Number: 2020-10734
Type: Notice
Date: 2020-05-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Scientific Botanical Pharmaceutical, Inc.
Document Number: 2020-10625
Type: Notice
Date: 2020-05-18
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.